Toggle navigation
Home
Search
Services
Blog
Contact
About
Fluid Fractionation of Pluronic 68 Surfactant
Krukonis, Val J.
Phasex Corporation, Lexington, MA, United States
Search 5 grants from Val Krukonis
Search grants from Phasex Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Environmental Health Research Experience Program
Partners Research Education Program
Improved Quantification, Coverage/Dynamic Range, Sensitivity, and Throughput
Program of Excellence in Practice and Dissemination of Motivational Interviewing
Behavioral Pharmacology of Opiate-Like Neuropeptides
Recently added grants:
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
The Role of Tumor-Infiltrating Immune Cells and Estrogen Receptor Expression in Racial Disparities in Breast Cancer Biology.
Application of a humanized patient-derived xenograft mouse model to assess the preclinical efficacy of combined chemohyperthermia and chimeric TRAIL treatment in ovarian peritoneal carcinomatosis
Effects of opiates on neurons and their impact on HIV neuropathology
Optimizing Genetic Testing for Deafness for Clinical Diagnostics
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Blood Diseases And Resources (NHLBI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43HB057005-000
Application #
3645488
Study Section
Project Start
1985-06-14
Project End
Budget Start
1985-06-14
Budget End
1985-12-13
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Phasex Corporation
Department
Type
DUNS #
City
Lexington
State
MA
Country
United States
Zip Code
Related projects
NIH 1986
N43 HB
Fluid Fractionation of Pluronic 68 Surfactant
Krukonis, Val J. / Phasex Corporation
NIH 1985
N43 HB
Fluid Fractionation of Pluronic 68 Surfactant
Krukonis, Val J. / Phasex Corporation
Comments
Be the first to comment on Val Krukonis's grant